AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 286: E744-E752, 2004. First published January 13, 2004; doi:10.1152/ajpendo.00489.2003
0193-1849/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
286/5/E744    most recent
00489.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (22)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eikelis, N.
Right arrow Articles by Esler, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eikelis, N.
Right arrow Articles by Esler, M.

Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function

Nina Eikelis,1,2 Gavin Lambert,1 Glen Wiesner,1 David Kaye,1 Markus Schlaich,1 Margaret Morris,3 Jacqueline Hastings,1 Florentia Socratous,1 and Murray Esler1

1Baker Heart Research Institute and 2Department of Medicine, Central and Eastern Clinical School, Monash University, and 3Department of Pharmacology, Melbourne University, Melbourne, Victoria 8008, Australia

Submitted 30 October 2003 ; accepted in final form 11 January 2004

The link between the human sympathoadrenalmedullary system and the adipocyte hormone leptin is controversial. We measured total and regional norepinephrine spillover, epinephrine secretion rate, and extra-adipocyte leptin release in 22 lean [body mass index (BMI) <26] and 20 obese (BMI >28) normotensive men who underwent arterial and central venous catheterization. Because plasma clearance of leptin is primarily by renal removal, for men at steady state we could estimate whole body leptin release to plasma from renal plasma leptin extraction. Whole body leptin release was 1,950 ± 643 (means ± SE) ng/min in obese men and 382 ± 124 ng/min in lean men (P < 0.05). Total and renal norepinephrine spillover rates correlated directly with whole body leptin secretion rate. Leptin is released from multiple nonadipocyte sites, which we tested by use of simultaneous arteriovenous blood sampling. We found a surprisingly large contribution of brain leptin release to the plasma leptin pool, 529 ± 175 ng/min (>40% whole body leptin release), with greater leptin release in obese than in lean men, 935 ± 321 vs. 160 ± 59 ng/min (P = 0.045). In parallel with leptin measurements, we also quantified brain serotonin turnover and jugular overflow of neuropeptide Y (NPY). Brain serotonin turnover was higher in obese than in lean men, 227 ± 112 vs. 21 ± 14 ng/min (P = 0.019), as was overflow of NPY from the brain, 12.9 ± 1.4 vs. 5.3 ± 2.2 ng/min (P = 0.042). These results suggest that leptin is released within the brain and at an increased rate in obese humans, in whom activation of brain serotonergic and NPY mechanisms also exists.

leptin; norepinephrine spillover; epinephrine secretion rate; 5-hydroxyindoleacetic acid; neuropeptide Y



Address for reprint requests and other correspondence: M. Esler, Baker Heart Research Institute, PO Box 6492, St. Kilda Road Central, Melbourne, Victoria 8008, Australia (E-mail: murray.esler{at}baker.edu.au).




This article has been cited by other articles:


Home page
HypertensionHome page
E. Lambert, N. Straznicky, M. Schlaich, M. Esler, T. Dawood, E. Hotchkin, and G. Lambert
Differing Pattern of Sympathoexcitation in Normal-Weight and Obesity-Related Hypertension
Hypertension, November 1, 2007; 50(5): 862 - 868.
[Abstract] [Full Text] [PDF]


Home page
Epidemiol RevHome page
S. Musaad and E. N. Haynes
Biomarkers of Obesity and Subsequent Cardiovascular Events
Epidemiol. Rev., May 10, 2007; (2007) mxm005v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Diepvens, K. R. Westerterp, and M. S. Westerterp-Plantenga
Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R77 - R85.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Esler and N. Eikelis
Is obstructive sleep apnea the cause of sympathetic nervous activation in human obesity?
J Appl Physiol, January 1, 2006; 100(1): 11 - 12.
[Full Text] [PDF]


Home page
Exp PhysiolHome page
N. Eikelis and M. Esler
The neurobiology of human obesity
Exp Physiol, September 1, 2005; 90(5): 673 - 682.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.